The independent pharmacy lobby is urging state legislatures to enact new legislation targeting pharmacy benefit managers (PBMs) that would increase fees and/or add surcharges to transactions with pharmacies. This is based upon two arguments: 1) that independent pharmacies are becoming
Pennsylvania State Facts & Resources PBM Savings and Patient Impact in Pennsylvania Pharmacy benefit experts secure lower prescription drug costs and enable better health outcomes for patients. PBMs will save Pennsylvanians $45B across all Pennsylvania insurance markets over ten years
Using a gold-standard pharmacy dataset from the National Council for Prescription Drug Programs (NCPDP) and a transparent methodology, PCMA produces credible research with a clear conclusion: there are more independent pharmacies now than any time over the last decade.
JC Scott (00:08): Welcome to the Pharmacy Benefit, a podcast where we talk about issues impacting patients, consumers, and affordable access to prescription drugs and better healthcare through the work being done by pharmacy benefit managers or PBMs. I’m
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
By JC Scott, President and CEO, PCMA In the past few years, some have been pushing the narrative that pharmacy benefit companies are driving independent pharmacies out of business. Their argument seems compelling, but is it true? As we do
Recent small fluctuations year-to-year in the number of independent pharmacies has not dramatically shifted the independent pharmacy market and continues to foster a stable market.
PBMs Support and Encourage Biosimilar Competition Increased biosimilar competition drives down prescription drug costs Having multiple biosimilar and reference biologic competitor products with equivalent patient benefits on the market allows pharmacy benefit companies, PBMs, to push manufacturers to compete on
Katie Payne Senior Vice President, Public Affairs and Head of Advocacy Katie (Carr) Payne is Senior Vice President, Public Affairs and Head of Advocacy at PCMA. In this role, Katie is responsible for leading PCMA’s communications function and oversees the association’s
The PCMA Foundation’s mission is to provide grants to academic researchers and non-profit organizations to support independent non-partisan research projects. The PCMA Foundation is the non-profit arm of the Pharmaceutical Care Management Association (PCMA). Researchers who are interested in being
©2024 PCMA. All Rights Reserved.
